Cited by 3Protein Degradation and InhibitorsUbiquitin and proteasome pathwaysHeat shock proteins research

Specific proteolysis mediated by a p97-directed proteolysis-targeting chimera (p97-PROTAC)

Open access
Salinas-Rebolledo, Constanza, Blesa, Javier, Valenzuela-Nieto, Guillermo, Schwefel, David, López-González del Rey, Natalia, Méndez-Ruette, Maxs, Burkhalter, Janine, Carrazana, Elizabeth +10 more·2025·eLife

Published version of a preprint

Abstract

The p97 protein is a member of the AAA+ family of ATPases. This protein is encoded by the VCP gene. It is a mechanoenzyme that uses energy from ATP hydrolysis to promote protein unfolding and segregation actively. The unfolded products are subsequently presented to the 26S proteasome for degradation. p97 substrate recognition is mediated by adaptors, which interact with substrates directly or indirectly through ubiquitin modifications, resulting in substrate funnelling into the central pore of the p97 hexamer and unfolding. Here, we engineered synthetic adaptors to target specific substrates to p97, using the extraordinary intracellular binding capabilities of camelid nanobodies fused to the UBX domain of the p97 adaptor protein Fas-associated factor-1 (FAF1). In such a way, we created a p97-directed proteolysis-targeting chimera (PROTAC), representing a novel and unique E3 ubiquitin ligase-independent strategy to promote specific proteolysis. All functional assays were performed in human cell lines to evaluate the system’s efficacy and specificity in a physiologically relevant context.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7554/elife.101496

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Authors
Salinas-Rebolledo, C., Blesa, J., Valenzuela-Nieto, G., Schwefel, D., López-González del Rey, N., Méndez-Ruette, M., Burkhalter, J., Carrazana, E., Díaz-Tejeda, F., Arias Catalán, I., Cappelli Leon, C., Salvadores, N., Bátiz, L. F., Jara, R., Obeso, J. A., Chana-Cuevas, P., Sapkota, G. P., & Rojas-Fernandez, A.
Affiliations
  • Austral University of Chile (CL)
  • HM Hospitales (ES)
  • Biotechnological Exploration Laboratory, Health Care Science Faculty, Universidad San Sebastian
  • Technische Universität Berlin (DE)
  • HM CINAC (Centro Integral de Neurociencias Abarca Campal), Hospital Universitario HM Puerta del Sur, HM Hospitales
  • Universidad de Los Andes (CO)
  • Universidad Mayor (CL)
  • Immunoepigenetics Laboratory, Institute of Biochemistry and Microbiology, Faculty of Sciences, Universidad Austral de Chile
  • CETRAM & Faculty of Medical Science Universidad de Santiago de Chile
  • University of Dundee (GB)
  • Institute of Medicine, Faculty of Medicine, Universidad Austral de Chile
Venue
eLife
Published
2025-11-26
Volume
14
ISSN
2050-084X (ISSN-L)
OpenAlex
W4416723086
Cited by
3
References
7
Citations by year
2026: 3
FWCI
0.90
Type
journal article
Language
en
Open access
Locations
  • eLife (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • Discovery Research Portal (University of Dundee) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Comunidad de Madrid (S2017/BMD-3700, S2017/BMD)
  • Deutsche Forschungsgemeinschaft
  • Swedish Foundation for International Cooperation in Research and Higher Education
  • Max-Planck-Gesellschaft (190011)
  • Agencia Nacional de Investigación y Desarrollo (MPG190011, 190011, 13220075, 3220635, T010047, 1200427, 21170632, FB210008)
  • Instituto de Salud Carlos III (CP19/00200, PI20/00496, FIS PI20/00496)
  • Fondo Nacional de Desarrollo Científico y Tecnológico (13220075, 3220635, 1200427)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
Keywords
VCP, PROTACs, FAF1, UBX domain, camelid nanobodies, protein unfolding, 26S proteasome, substrate recognition, ATPase
MeSH terms
Valosin Containing Protein, Adenosine Triphosphatases, Humans, Recombinant Fusion Proteins, Adaptor Proteins, Signal Transducing, Proteolysis, Single-Domain Antibodies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review